Abstract
With the development of scientific research techniques, drug discovery has shifted from the serendipitous approach of the past to more targeted models based on an understanding of the underlying biological mechanisms of disease. However, there are hundreds or more of mechanism of action (MoA) data in the known drugs, which makes this process faced with complicated multi-label classification of text data. Traditional multi-label text classification algorithms will increase the complexity of the model and reduce the accuracy as the number of labels increases. Although deep learning algorithms can solve the problem of model complexity, they are currently only suitable for processing image format data. To overcome these problems, this study proposes a multi-label classification method based on Bayesian deep learning, which can convert non-image data format into image data, making it suitable for Convolutional neural network algorithm requirements. Then in the PyTorch environment, the Bayesian deep learning algorithm and the EfficientNet convolutional neural network are perfectly combined using the BLiTZ library to construct the Bayesian convolutional neural network model which named BCNNM. Not only improves the classification efficiency, this method also solves the problem of imbalanced classification of multi-label data, and fully considers the uncertainty in the neural network. In the process of drug development, this method has important practical significance for processing the multi-label classification of MoA data.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: ACM Transactions on Asian and Low-Resource Language Information Processing
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.